Follow-The-Filings

Security

BCRX

Biocryst Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

13 owners 2 new 2 exits max 0.1% (Two Sigma Investments, LP)

grid → activity →
owners 13
max % 0.1%
tracked value $274M
qoq N 2 A 5 R 4 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Two Sigma Investments, LP 2025 Q4 stale 0.1% Exit -0.05 pp 4,515,317 $35M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Add +0.02 pp 638,054 $6M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 2,733,253 $26M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce -0.01 pp 776,990 $7M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 312,961 $3M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 22,273,375 $174M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 1,018,743 $10M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 440,141 $4M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 302,101 $3M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 246,477 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 187,721 $2M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 186,125 $2M hist
Farallon Capital Management LLC 2026 Q1 0.0% — 24,000 $228 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.01 pp 1,213,576 $9M hist
Norges Bank exited 2025 Q4 last 2025 Q2 0.0% Exit 0.00 pp 111,152 $996 hist

13 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $331.41M $450.71M $874.84M
Gross profit * $326.93M $438.44M $855.76M
Gross margin * 98.6% 97.3% 97.8%
Net income -$226.54M -$88.88M $263.86M
Net margin * -68.4% -19.7% 30.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $495.97M $421.97M $404.35M
Total non-current assets * $20.99M $68.45M $109.81M
Total assets $516.96M $490.42M $514.16M
Total current liabilities $149.99M $160.38M $196.07M
Total non-current liabilities * — $805.97M $437.24M
Total equity -$455.53M -$475.93M -$119.15M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$95.14M -$52.02M $347.37M
Cash from investing -$131.5M $52.59M -$13.69M
Cash from financing $32.48M -$5.76M -$349.93M
Net change in cash -$193.79M -$6.12M -$14.99M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders